Kari Saunamäki

Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trial

Thomas Engstrøm, Henning Kelbæk, Steffen Helqvist et al. · The Lancet · 2015 · 947 citations

Percutaneous Coronary Intervention, Cardiovascular Disease, Complete Revascularisation +9

Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction

Jacob Lønborg, Niels Vejlstrup, Henning Kelbæk et al. · European Heart Journal · 2011 · 538 citations · Full text

Identification of vulnerable plaques and patients by intracoronary near-infrared spectroscopy and ultrasound (PROSPECT II): a prospective natural history study

David Erlinge, Akiko Maehara, Ori Ben‐Yehuda et al. · The Lancet · 2021 · 423 citations

Medical Ultrasound, Engineering, Vascular Image +12

Short- and Long-Term Cause of Death in Patients Treated With Primary PCI for STEMI

Frants Pedersen, Vitalij Butrymovich, Henning Kelbæk et al. · Journal of the American College of Cardiology · 2014 · 409 citations

Patients Treated, Cardiovascular Disease, Primary Pci +2

Effect of remote ischaemic conditioning on clinical outcomes in patients with acute myocardial infarction (CONDI-2/ERIC-PPCI): a single-blind randomised controlled trial

Derek J. Hausenloy, Rajesh Kharbanda, Ulla Møller et al. · The Lancet · 2019 · 309 citations · Full text